세계의 반려동물 의료 시장 규모 : 유형별, 제품별, 유통 채널별, 최종사용자별, 지역별 범위 및 예측

Global Companion Animal Health Market Size By Type, By Product, By Distribution Channel, By End-User, By Geographic Scope And Forecast

US $ 3,950 ￦ 5,411,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 보고서의 다운로드와 인쇄가 가능합니다.

US $ 4,850 ￦ 6,644,000

PDF & Excel (5 User License)

PDF 및 Excel 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 보고서의 다운로드와 인쇄가 가능합니다.

US $ 7,550 ￦ 10,344,000

PDF & Excel (Enterprise User License)

PDF 및 Excel 보고서를 동일기업내 모든 분들이 이용할 수 있는 라이선스입니다. 보고서의 다운로드와 인쇄가 가능합니다.

한글목차

반려동물 의료 시장 규모 및 전망

반려동물 의료 시장 규모는 2024년 224억 8,000만 달러로 평가되며, 2026년부터 2032년까지 CAGR 8.49%로 성장하여 2032년에는 431억 4,000만 달러에 달할 것으로 예상됩니다.

• 반려동물 의료는 반려동물의 정기적인 모니터링과 관리를 통해 생명을 위협할 수 있는 질병과 장애를 발견하고 치료하는 것을 포함합니다. 이 분야에는 유전체 진단, 디지털 기술, 항암제, 치료용 백신, 단클론항체 요법 등 다양한 발전이 포함됩니다.
• 이러한 기술 혁신은 조기 진단과 효과적인 치료를 실현하고 반려동물에게 더 나은 결과를 가져다 줄 수 있는 필수적인 요소입니다.
• 최근 반려동물의 전반적인 건강과 복지에 대한 인식이 높아지면서 반려동물 보호자의 수가 눈에 띄게 증가하고 있습니다. 이러한 지식을 가진 보호자들은 반려동물의 건강을 유지하기 위해 적극적으로 동물병원을 찾고 있으며, 반려동물 의료 분야의 성장에 기여하고 있습니다.
• 예방 치료와 고급 치료에 대한 관심은 인간의 건강 관리에서 유사한 발전과 유사하게 반려동물의 삶의 질을 향상시키려는 광범위한 추세를 반영합니다.
• 반려동물을 키우는 세계 인구가 지속적으로 증가함에 따라 반려동물 의료 시장은 혁신적인 헬스케어 솔루션과 보다 쉽게 이용할 수 있는 수의학 서비스에 대한 수요 증가로 인해 더욱 확대될 것으로 예상됩니다. 반려동물 의료에 대한 관심이 높아짐에 따라 반려동물의 행복을 위한 조기 개입과 종합적인 치료의 중요성이 부각되고 있습니다.

반려동물 의료 세계 시장 역학

반려동물 의료 세계 시장을 형성하고 있는 주요 시장 역학은 다음과 같습니다:

주요 시장 촉진요인

• 세계 반려동물 보유율 증가 : 세계 반려동물 보유율 증가 : 세계 반려동물 보유율 증가는 반려동물 의료 시장의 주요 촉진요인이며, 반려동물 증가는 수의학 치료 및 건강 제품에 대한 수요 증가로 이어집니다. 미국 반려동물용품협회(APPA)의 2021-2022년 전국 반려동물 양육자 조사에 따르면, 미국 가구의 70%가 반려동물을 키우고 있으며, 이는 9,050만 가구에 해당합니다.
• 반려동물 의료관리에 대한 지출 증가 : 반려동물 보호자들은 반려동물의 건강에 더 많은 돈을 쓰고 싶어하며 반려동물 의료 시장의 성장을 주도하고 있습니다. American Pet Products Association의 보고서에 따르면, 2020년 미국인들은 수의학 치료 및 제품에 314억 달러를 지출했으며, 2021년에는 이 수치가 323억 달러에 달할 것으로 추정됩니다.
• 인수공통전염병의 확산 : 인수공통전염병(동물과 사람 사이에 전염될 수 있는 질병)의 증가로 인해 더 나은 반려동물용 의료 제품 및 서비스에 대한 수요가 증가하고 있습니다. 세계보건기구(WHO)에 따르면, 인간에게 알려진 전염병의 약 60%, 신규 또는 신흥 전염병의 75%가 인수공통전염병입니다.

주요 과제

• 수의학 및 치료비 상승 : 수의학 서비스 및 동물용 의약품에 대한 비용 증가는 많은 보호자들에게 큰 장벽이 되어 시장 성장을 제한할 수 있습니다. 미국수의사회(AVMA)에 따르면, 2016년 가구당 평균 동물의료비는 개 410달러, 고양이 275달러였습니다. 미국 반려동물용품협회(APPA)의 보고서에 따르면 동물 의료비는 꾸준히 증가하고 있으며, 미국 반려동물 산업의 총 지출은 2018년 905억 달러에서 2020년에는 1,036억 달러로 증가할 것으로 예상했습니다.
• 수의사 인력 부족 : 자격을 갖춘 수의사 및 수의사 기술자 부족은 동물 건강 관리 서비스에 대한 접근성을 제한하고 시장 성장을 저해할 수 있습니다. 미국 노동 통계청은 2020년에서 2030년까지 수의사 고용이 17% 증가할 것으로 예상하고 있으며, 이는 전체 직업의 평균보다 훨씬 빠른 속도입니다. 그러나 이러한 성장은 수요를 따라잡지 못하고 있으며, Mars Veterinary Health의 2019년 조사에 따르면 2030년까지 미국에서 7만 5,000명의 수의사가 부족할 것으로 예측하고 있어 수요와 공급 사이에 큰 격차가 있을 것으로 보입니다.
• 동물용 의약품의 엄격한 규제 승인 : 새로운 동물용 의약품에 대한 엄격한 규제와 긴 승인 절차는 새로운 치료법의 혁신과 시장 진입을 지연시킬 수 있습니다. 미국 식품의약국(FDA) 동물용 의약품센터(CVM)의 보고에 따르면, 2020년 신규 동물용 의약품 신청(NADA) 승인에 소요되는 평균 기간은 295일이었습니다.

주요 동향

• 수의학에서 원격의료 도입 증가 : 수의학에서 원격의료의 활용이 빠르게 확대되고 있으며, 반려동물 보호자는 수의사 진료 및 경과 관찰에 편리하게 접근할 수 있으며, 2020년 미국수의사회(AVMA)의 조사에 따르면, COVID-19 팬데믹 기간 동안 원격진료를 이용한 수의학 기관은 32%였습니다. 기관은 32%였습니다. 미국동물병원협회(AAHA)의 보고에 따르면, 반려동물 보호자의 30%가 반려동물의 건강관리에 원격의료 서비스를 이용하는 것에 관심을 보이고 있습니다.
• 반려동물 웨어러블 및 건강 모니터링 기기 시장의 성장 : 반려동물 케어의 기술 통합, 특히 웨어러블 기기와 건강 모니터링 도구는 반려동물 의료 시장의 새로운 트렌드입니다.
• 개인화 및 예방 수의학의 부상 : 반려동물 의료 분야에서는 유전자 검사, 맞춤형 영양 계획 등 개인화 의료 및 예방 의료에 대한 관심이 높아지고 있습니다.

목차

제1장 반려동물 의료 세계 시장 소개

• 시장 개요
• 조사 범위
• 가정

제2장 주요 요약

제3장 VERIFIED MARKET RESEARCH 조사 방법

• 데이터 마이닝
• 검증
• 1차 자료
• 데이터 소스 리스트

제4장 반려동물 의료 세계 시장 전망

• 개요
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• Porter's Five Forces 모델
• 밸류체인 분석

제5장 반려동물 의료 세계 시장 : 유형별

• 개요
• 개
• 고양이
• 말

제6장 반려동물 의료 세계 시장 : 제품별

• 개요
• 치료제
• 진단
• 백신
• 의약품

제7장 반려동물 의료 세계 시장 : 유통 채널별

• 개요
• 소매
• E-Commerce
• 병원 약국

제8장 반려동물 의료 세계 시장 : 최종사용자별

• 개요
• 원내 검사
• 동물 병원 및 진료소
• 표준 실험실

제9장 반려동물 의료 세계 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 기타 유럽
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 기타 아시아태평양
• 세계 기타 지역
  • 라틴아메리카
  • 중동 및 아프리카

제10장 세계의 반려동물 의료 시장 경쟁 구도

• 개요
• 각사의 시장 순위
• 주요 발전 전략

제11장 기업 개요

• Merck & Co., Inc.
• Ceva
• Vetoquinol S.A.
• Zoetis
• Boehringer Ingelheim GmbH
• IDEXX Laboratories, Inc.
• Elanco
• Indian Immunologicals Ltd.
• Virbac
• Agrolabo SpA,
• Norbrook

제12장 부록

• 관련 조사

ksm

영문 목차

영문목차

Companion Animal Health Market Size And Forecast

The Companion Animal Health Market size was valued at USD 22.48 Billion in 2024 and is projected to reach USD 43.14 Billion by 2032, growing at a CAGR of 8.49% from 2026-2032.

• Companion animal health involves the regular monitoring and care of pets to detect and treat illnesses or disorders that could threaten their lives if left untreated. This field encompasses a wide range of advancements, including genomic diagnostics, digital technologies, anti-cancer medications, therapeutic vaccines, and monoclonal antibody therapies.
• These innovations are critical for early diagnosis and effective treatment, ensuring better outcomes for companion animals.
• In recent years, there has been a notable rise in the number of pet owners who are increasingly aware of their pets' overall health and welfare. These informed pet owners actively seek veterinary care to maintain their pets' well-being, contributing to the growth of the companion animal health sector.
• The focus on preventive care and advanced treatments reflects a broader trend towards enhancing the quality of life for pets, paralleling similar advancements in human healthcare.
• As the global population of pet owners continues to grow, the companion animal health market is expected to expand further, driven by increased demand for innovative healthcare solutions and more accessible veterinary services. This growing focus on companion animal health highlights the importance of early intervention and comprehensive care for the well-being of pets.

Global Companion Animal Health Market Dynamics

The key market dynamics that are shaping the global companion animal health market include:

Key Market Drivers

• Increasing Pet Ownership Rates Globally: The growing number of pet owners worldwide is a key driver for the companion animal health market, as more pets lead to higher demand for veterinary care and health products. According to the American Pet Products Association's (APPA) 2021-2022 National Pet Owners Survey, 70% of U.S. households own a pet, which equates to 90.5 million homes.
• Rising Expenditure on Pet Healthcare: Pet owners are increasingly willing to spend more on their pets' health, driving growth in the companion animal health market. The American Pet Products Association reports that in 2020, Americans spent USD 31.4 Billion on veterinary care and products, and this figure is estimated to have reached USD 32.3 Billion in 2021.
• Growing Prevalence of Zoonotic Diseases: The increasing occurrence of zoonotic diseases (diseases that can be transmitted between animals and humans) is driving demand for better companion animal health products and services. According to the World Health Organization (WHO), approximately 60% of known infectious diseases in humans and 75% of new or emerging infectious diseases are zoonotic.

Key Challenges

• High Cost of Veterinary Care and Treatments: The increasing cost of veterinary services and animal health products can be a significant barrier for many pet owners, potentially limiting market growth. According to the American Veterinary Medical Association (AVMA), the average veterinary expenditure per household for dogs was $410 in 2016, while for cats it was $275. The American Pet Products Association (APPA) reports that veterinary care costs have been steadily rising, with total U.S. pet industry expenditures increasing from USD 90.5 Billion in 2018 to USD 103.6 Billion in 2020.
• Shortage Of Veterinary Professionals: A lack of qualified veterinarians and veterinary technicians can limit access to animal healthcare services, restraining market growth. The U.S. Bureau of Labor Statistics projects that employment of veterinarians will grow 17% from 2020 to 2030, much faster than the average for all occupations. However, this growth is not keeping pace with demand. A 2019 study by Mars Veterinary Health predicted a shortage of 75,000 veterinarians in the U.S. by 2030, indicating a significant gap between supply and demand.
• Stringent Regulatory Approvals for Animal Health Products: Strict regulations and lengthy approval processes for new animal health products can slow down innovation and market entry for new treatments. The U.S. Food and Drug Administration's Center for Veterinary Medicine (CVM) reports that the average time for approval of a new animal drug application (NADA) was 295 days in fiscal year 2020.

Key Trends

• Increasing Adoption of Telemedicine in Veterinary Care: The use of telemedicine in veterinary practice is growing rapidly, offering pet owners convenient access to veterinary consultations and follow-ups. According to a survey by the American Veterinary Medical Association (AVMA) in 2020, 32% of veterinary practices were using telemedicine to provide care during the COVID-19 pandemic. The American Animal Hospital Association (AAHA) reports that 30% of pet owners expressed interest in using telemedicine services for their pets' healthcare needs.
• The Growing Market for Pet Wearables and Health Monitoring Devices: The integration of technology in pet care, particularly through wearable devices and health monitoring tools, is an emerging trend in the companion animal health market.
• Rise in Personalized and Preventive Veterinary Medicine: There's a growing trend towards personalized and preventive care in companion animal health, including genetic testing and tailored nutrition plans.

Global Companion Animal Health Market Regional Analysis

Here is a more detailed regional analysis of the global companion animal health market:

Europe

• Europe substantially dominates the global companion animal health market owing to the high pet ownership rates and increasing pet humanization.
• Europe has one of the highest pet ownership rates globally, with a growing trend of treating pets as family members, leading to increased spending on pet health.
• According to the European Pet Food Industry Federation (FEDIAF), as of 2021, 88 million households in the EU own a pet. This represents 46% of all households in the EU. Dogs are the most popular, with 90 million dogs in European households.
• Europe boasts a well-developed veterinary healthcare system, with a high number of veterinary professionals and advanced facilities.
• The Federation of Veterinarians of Europe (FVE) reports that as of 2019, there were approximately 309,000 veterinarians in Europe, with a ratio of about 1 veterinarian per 2,000 inhabitants. This high density of veterinary professionals contributes to better access to pet healthcare services.
• European countries have some of the world's most comprehensive animal welfare laws, driving demand for high-quality pet healthcare products and services.
• The European Union has implemented various regulations to ensure animal welfare, including Regulation (EU) 2019/6 on veterinary medicinal products, which came into effect in January 2022.

North America

• North America is anticipated to witness the fastest growth in the global companion animal health market during the forecast period driven by the increasing pet expenditure.
• North America, particularly the United States, has one of the highest pet ownership rates globally, with significant spending on pet health and wellness.
• According to the American Pet Products Association (APPA) 2021-2022 National Pet Owners Survey, 70% of U.S. households own a pet, which equates to about 90.5 million homes. The same survey reports that Americans spent $123.6 billion on their pets in 2021, with USD 34.3 Billion specifically on veterinary care and product sales.
• Advanced veterinary healthcare infrastructure and technology adoption. North America boasts a highly developed veterinary healthcare system with widespread adoption of advanced technologies.
• The American Veterinary Medical Association (AVMA) reports that as of 2021, there were approximately 120,652 veterinarians in the United States.
• Increasing prevalence of chronic diseases in pets: The rising incidence of chronic diseases in companion animals is driving demand for advanced treatments and long-term care.
• According to Banfield Pet Hospital's 2020 Veterinary Emerging Topics (VET) Report, chronic kidney disease diagnoses in cats increased by 31% from 2009 to 2019. The same report noted that 51% of dogs and 44% of cats in the U.S. were classified as overweight or obese in 2019, conditions that can lead to various chronic health issues requiring ongoing medical care.

Global Companion Animal Health Market: Segmentation Analysis

The Global Companion Animal Health Market is segmented based on Type, Product, Distribution Channel, End-User, And Geography.

Companion Animal Health Market, By Type

• Dogs
• Cats
• Equine

Based on the Type, the Global Companion Animal Health Market is bifurcated into Dogs, Cats, and Equine. The dog segment dominates the global companion animal health market, fueled by increasing awareness of pet health insurance among dog owners. A growing number of covered dogs reflects this trend, as more owners acknowledge the financial benefits and protection that pet insurance offers. This shift alleviates the high costs associated with veterinary services and encourages regular veterinary visits and preventive care.

Companion Animal Health Market, By Product

• Therapeutics
• Diagnostics
• Vaccines
• Pharmaceuticals
• OTC

Based on the Product, the Global Companion Animal Health Market is bifurcated into Therapeutics, Diagnostics, Vaccine, Pharmaceuticals, and OTC. The pharmaceuticals segment dominates the global companion animal health market owing to the rising prevalence of food-borne diseases, brucellosis, and zoonotic diseases that pose significant risks to animals, creating an urgent need for effective medications. Additionally, the substantial increase in animal bite incidents heightens the risk of disease transmission and microbial infections, further driving demand for pharmaceuticals.

Companion Animal Health Market, By Distribution Channel

• Retail
• E-Commerce
• Hospital Pharmacies

Based on the Distribution Channel, the Global Companion Animal Health Market is bifurcated into Retail, E-Commerce, and Hospital Pharmacies. The hospital pharmacies segment dominates the global companion animal health market, driven by the rising prevalence of chronic diseases and various epidemics affecting pets. Hospitals offer advanced treatment products that contribute significantly to this segment's growth. The high procedural volume, stemming from frequent readmissions of pets for ongoing treatment, further supports this trend.

Companion Animal Health Market, By End-User

• In House Testing
• Veterinary Hospitals and Clinics
• Reference Laboratories

Based on End-User, the Global Companion Animal Health Market is bifurcated into In-House Testing, Veterinary Hospitals and Clinics, and Reference Laboratories. The veterinary hospitals and clinics segment significantly dominates in the global companion animal health market, driven by various applications such as therapy, toxicological testing, and clinical pathology. This segment's growth is significantly influenced by the availability of certain vaccines exclusively at accredited veterinary facilities. Additionally, recent years have seen an expansion of opportunities for this segment, as numerous government and animal welfare organizations have implemented regulations and standards for safety practices in veterinary hospitals and clinics.

Companion Animal Health Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Companion Animal Health Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. Europe substantially dominates the global companion animal health market owing to the high pet ownership rates and increasing pet humanization. Europe has one of the highest pet ownership rates globally, with a growing trend of treating pets as family members, leading to increased spending on pet health. According to the European Pet Food Industry Federation (FEDIAF), as of 2021, 88 million households in the EU own a pet. This represents 46% of all households in the EU. Dogs are the most popular, with 90 million dogs in European households. Europe boasts a well-developed veterinary healthcare system, with a high number of veterinary professionals and advanced facilities.

Key Players

The "Global Companion Animal Health Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Merck & Co., Inc., Ceva, Vetoquinol S.A., Zoetis, Boehringer Ingelheim GmbH, IDEXX Laboratories, Inc., Elanco, Indian Immunologicals Ltd., Virbac, Agrolabo SpA, Norbrook.

• This section offers in-depth analysis through a company overview, position analysis, the regional and industrial footprint of the company, and the ACE matrix for insightful competitive analysis. The section also provides an exhaustive analysis of the financial performances of mentioned players in the given market.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Companion Animal Health Market Key Developments

• In June 2023, Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, announced today that the European Commission has approved INNOVAX(R)-ILT-IBD, a dual-construct HVT vaccine that provides long-term protection against infectious laryngotracheitis (ILT), infectious bursal disease (IBD), and Marek's disease (MD).
• In May 2023, Merck Animal Health announced that the Australian Pesticides and Veterinary Medicines Authority (APVMA) had approved a novel injectable formulation of BRAVECTO(R) (fluralaner) for the treatment and prevention of flea (Ctenocephalides felis) infestations for 12 months, control of paralysis tick (Ixodes holocyclus) for 12 months, control of brown dog tick (Rhipicephalus sanguineus) for 11 months, and control of flea allergy dermatitis.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL COMPANION ANIMAL HEALTH MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL COMPANION ANIMAL HEALTH MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL COMPANION ANIMAL HEALTH MARKET, BY TYPE

• 5.1 Overview
• 5.2 Dogs
• 5.2 Cats
• 5.3 Equine

6 GLOBAL COMPANION ANIMAL HEALTH MARKET, BY PRODUCT

• 6.1 Overview
• 6.2 Therapeutics
• 6.3 Diagnostics
• 6.4 Vaccines
• 6.5 Pharmaceuticals

OTC7 GLOBAL COMPANION ANIMAL HEALTH MARKET, BY DISTRIBUTION CHANNEL

• 7.1 Overview
• 7.2 Retail
• 7.3 E-Commerce
• 7.4 Hospital Pharmacies

8 GLOBAL COMPANION ANIMAL HEALTH MARKET, BY END USER

• 8.1 Overview
• 8.2 In House Testing
• 8.3 Veterinary Hospitals and Clinics
• 8.4 Reference Laboratories

9 GLOBAL COMPANION ANIMAL HEALTH MARKET, BY GEOGRAPHY

• 9.1. Overview
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. U.K.
  • 9.3.3. France
  • 9.3.4. Rest of Europe
• 9.4. Asia Pacific
  • 9.4.1. China
  • 9.4.2. Japan
  • 9.4.3. India
  • 9.4.4. Rest of Asia Pacific
• 9.5. Rest of the World
  • 9.5.1. Latin America
  • 9.5.2. Middle East & Africa

10 GLOBAL COMPANION ANIMAL HEALTH MARKET COMPETITIVE LANDSCAPE

• 10.1 Overview
• 10.2 Company Market Ranking
• 10.3 Key Development Strategies

11 COMPANY PROFILES

• 11.1 Merck & Co., Inc.
  • 11.1.1 Overview
  • 11.1.2 Financial Performance
  • 11.1.3 Product Outlook
  • 11.1.4 Key Developments
• 11.2 Ceva
  • 11.2.1 Overview
  • 11.2.2 Financial Performance
  • 11.2.3 Product Outlook
  • 11.2.4 Key Developments
• 11.3 Vetoquinol S.A.
  • 11.3.1 Overview
  • 11.3.2 Financial Performance
  • 11.3.3 Product Outlook
  • 11.3.4 Key Developments
• 11.4 Zoetis
  • 11.4.1 Overview
  • 11.4.2 Financial Performance
  • 11.4.3 Product Outlook
  • 11.4.4 Key Developments
• 11.5 Boehringer Ingelheim GmbH
  • 11.5.1 Overview
  • 11.5.2 Financial Performance
  • 11.5.3 Product Outlook
  • 11.5.4 Key Developments
• 11.6 IDEXX Laboratories, Inc.
  • 11.6.1 Overview
  • 11.6.2 Financial Performance
  • 11.6.3 Product Outlook
  • 11.6.4 Key Developments
• 11.7 Elanco
  • 11.7.1 Overview
  • 11.7.2 Financial Performance
  • 11.7.3 Product Outlook
  • 11.7.4 Key Developments
• 11.8 Indian Immunologicals Ltd.
  • 11.8.1 Overview
  • 11.8.2 Financial Performance
  • 11.8.3 Product Outlook
  • 11.8.4 Key Developments
• 11.9 Virbac
  • 11.9.1 Overview
  • 11.9.2 Financial Performance
  • 11.9.3 Product Outlook
  • 11.9.4 Key Developments
• 11.10 Agrolabo SpA,
  • 11.10.1 Overview
  • 11.10.2 Financial Performance
  • 11.10.3 Product Outlook
  • 11.10.4 Key Developments
• 11.11 Norbrook
  • 11.11.1 Overview
  • 11.11.2 Financial Performance
  • 11.11.3 Product Outlook
  • 11.11.4 Key Developments

12 APPENDIX

• 12.1 Related Research

관련자료